Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-05

Clinical Trial Update: Lymphocyte Infusions for the Treatment of HIV-Infected Patients Failing Anti-HIV Therapy [Phase 1]

View source ↗

Summary

Phase 1 study of lymphocyte infusions for HIV-infected patients failing antiretroviral therapy has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lymphocyte infusion

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: HIV Infections | Phase 1 | Status: TERMINATED